Papers
20
Total Citations
365
H-Index
10
About
Xu Zhang is a prominent urological surgeon and researcher whose work has significantly advanced the field of minimally invasive kidney surgery, particularly partial nephrectomy for renal tumors. His research focuses on comparing and optimizing surgical approaches—including robot-assisted, laparoscopic, and open techniques—for complex renal masses, with a consistent emphasis on perioperative safety, functional preservation, and oncological outcomes. Zhang's most influential contributions include rigorous matched-pair and propensity score analyses examining robot-assisted partial nephrectomy (RAPN) versus laparoscopic approaches across tumor subgroups defined by anatomical complexity, size, and location. His 2016 study comparing robotic and open partial nephrectomy for complex tumors has garnered 68 citations, establishing him as a leading voice in surgical strategy optimization. His work on surgical access routes—transperitoneal versus retroperitoneal—has provided clinicians with evidence-based guidance for tailoring approaches to individual tumor characteristics. Beyond nephron-sparing surgery, Zhang has expanded into telesurgery, co-authoring influential frameworks for safe robotic telesurgical implementation, reflecting his forward-looking perspective on surgical innovation. A notable 2021 case report documenting pembrolizumab's complete response in HLRCC-associated renal cell carcinoma further demonstrates his breadth across surgical and oncological domains. With over 300 cumulative citations, Zhang's work continues to shape contemporary urological practice worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10